Mark Zuckerberg and wife Dr. Priscilla Chan recently announced a $3 billion initiative geared towards curing most of the world’s diseases called the Biohub. Through the Chan Zuckerberg Initiative, the couple managed to draw support from other billionaires and ordinary people alike in terms of funding and cooperation. Recently, the Facebook founder released a post detailing how a meeting with top scientists gave him hope that most, if not all of the world’s diseases will be gone by 2115.
The scientists in question are at the top of their fields with regards to dealing with illnesses and they come from multiple origins, including Stanford University and UC Berkeley. Heading the team is Dr. Cori Bargmann, who is a Rockefeller neuroscientist, Futurism reports.
Even with excellent brains behind the operation, the goal of eradicating even just a majority of the known diseases plaguing the world is a monumental undertaking. Much of the challenges has to do with research, which is a costly and time-consuming affair. The Biohub will take on a lot of the weight of the problems that usually prevent scientists from making swift progress, but even then, many would consider the 100-year timeline to be overly ambitious.
Zuckerberg and the team of scientists don’t seem to think so, however, and they point to the advancements that humanity has achieved in the last few decades in extending human lifespan. Global Futurist also notes how the initiative has already addressed one of the hurdles of getting to the point that they are aiming for; coordination.
There’s also the matter of the most recent innovations in medical and bioresearch to consider, which gives the lofty goals of a disease-free world a boost. There’s the new gene-editing tool called CRISPR, which is basically a starter kit for playing God. Then there’s the project called Cell Atlas, which aims to map all of the human body’s cells to address diseases that begin at the cellular level.


RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
SpaceX Stock Soars After Historic IPO, Reaches $2.5 Trillion Market Value
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Meta AI Strategy Faces Challenges as Zuckerberg Admits Mistakes in Internal Memo
SpaceX IPO Set for Explosive Debut as Valuation Tops $2.2 Trillion
SpaceX IPO Sparks Market Optimism as Shares Surge 19% on Trading Debut
TrumpRx Expands Discount Drug Access With 600 Generic Medications
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Why the future of marijuana legalization remains hazy despite high public support
Trump Says Anthropic No Longer Seen as National Security Threat
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
AI Memory Boom Sparks Global Chip Supply Crunch
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO 



